RA Capital Management - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$70,492,000
-18.1%
8,659,983
-18.8%
3.04%
-39.3%
Q4 2018$86,029,000
+22.1%
10,660,349
+15.4%
5.01%
+32.9%
Q3 2018$70,461,000
+76.1%
9,234,692
+32.2%
3.77%
+45.0%
Q2 2018$40,022,000
+20.1%
6,984,6920.0%2.60%
+1.8%
Q1 2018$33,317,000
-2.9%
6,984,6920.0%2.55%
-11.0%
Q4 2017$34,295,000
-6.3%
6,984,6920.0%2.87%
-13.2%
Q3 2017$36,600,000
+27.5%
6,984,692
+35.3%
3.31%
+0.4%
Q2 2017$28,702,000
-2.1%
5,162,242
+47.9%
3.29%
-8.4%
Q1 2017$29,314,000
+54.9%
3,489,795
+16.7%
3.60%
+34.1%
Q4 2016$18,925,000
+43.5%
2,989,7950.0%2.68%
+97.1%
Q3 2016$13,185,000
+55.3%
2,989,7950.0%1.36%
+15.6%
Q2 2016$8,491,000
+0.4%
2,989,7950.0%1.18%
+8.8%
Q1 2016$8,461,000
-73.5%
2,989,795
-3.4%
1.08%
-65.8%
Q4 2015$31,931,000
+134.1%
3,094,064
+158.6%
3.16%
+61.3%
Q3 2015$13,641,000
-64.9%
1,196,603
-54.1%
1.96%
-49.9%
Q2 2015$38,898,000
-37.8%
2,605,361
-62.4%
3.91%
-37.0%
Q1 2015$62,547,000
-27.0%
6,926,617
-1.8%
6.21%
-32.6%
Q4 2014$85,732,000
+24.0%
7,050,356
-0.3%
9.21%
+12.8%
Q3 2014$69,136,000
+69.5%
7,069,159
+121.0%
8.17%
+98.2%
Q2 2014$40,781,000
-11.3%
3,198,529
-26.4%
4.12%
+24.9%
Q1 2014$45,996,000
+39.2%
4,347,4560.0%3.30%
-14.3%
Q4 2013$33,041,000
-22.3%
4,347,456
-25.6%
3.85%
-13.3%
Q3 2013$42,549,0005,844,7004.44%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders